Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Astra drives FTSE higher as Pfizer waits in wings

Astra drives FTSE higher as Pfizer waits in wings

Healthcare stocks have led the running in early trading on the FTSE 100, with shares in AstraZeneca (AZN) rising on speculation US rival Pfizer (PFE.N) may make another bid for the pharmaceutical giant.

The UK blue-chip index added 19 points, or 0.3% to trade at 6,775. AstraZeneca rose 1.7% to 43.57 as investors bet Pfizer could return with another takeover approach. Pfizer made a series of failed bids for the company earlier in the year, and under takeover rules can make the first steps towards a new bid next week.

Fellow pharmaceutical group GlaxoSmithKline (GSK) rose 1.4% to £14.37 while medical equipment manufacturer Smith & Nephew (SN) rose 1.1% to £10.58.

Miners again performed poorly, after fresh concerns over growth of top metals consumer China emerged. Growth in the country’s factory sector slowed to a three-month low in August, new data revealed.

Fresnillo (FRES) was the biggest faller, dropping 3.4% to 939.5p, while Randgold Resources (RRS) dipped 1.4% to £49.26 and Rio Tinto (RIO) traded 0.5% lower at £34.40.

On the AIM market, Quindell (QPP) fell 4.4% to 201p after announcing profit nearly tripled in the first half of the year. However, much of the headline news from the results had already been delivered in the insurance claims outsourcing firm’s pre-close statement.

Quindell has endured a tumultuous 2014 after an attack from short selling group Gotham City Research, with its shares losing two-thirds of their value since hitting a peak of 660p in February.

The pound is meanwhile trading 0.1% down at $1.6577 after weak retail sales data. Retail sales volumes in July were up just 0.1% on the month, and 2.6% year-on-year, while the average price of goods in the month was 0.9% down on the same time last year.

'The significant year-on-year deflation in the retail sector reflects the strong competition among retailers and confirms there are no substantial inflationary pressures in the economy,' said David Kern, chief economist at the British Chambers of Commerce.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Big City Bright Future

Big City Bright Future

Big City Bright Future, the brainchild of BlackRock, is a three-week work experience programme for school leavers looking to forge a career in the City.

Play Kames' Ennett: Trump good for US high yield, but beware Europe

Kames' Ennett: Trump good for US high yield, but beware Europe

Kames Capital’s head of high yield David Ennett believes the changing political landscape will be a positive for the US, but negative for Europe in 2017.

Play Philip Milburn: why inflation won't run out of control

Philip Milburn: why inflation won't run out of control

Kames bond fund manager views inflation as more of 'scare' than a 'problem' and is positioning his portfolios accordingly.

Read More
Your Business: Cover Star Club

Profile: change is the only constant for Quilter Cheviot

Profile: change is the only constant for Quilter Cheviot

This is not the first time we have profiled David Miller, but at the time of his previous appearance his company looked very different.

Wealth Manager on Twitter